Stephen Joyce
Public Communications Contact bei AMRYT PHARMA PLC
Aktive Positionen von Stephen Joyce
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| AMRYT PHARMA PLC | Public Communications Contact | - | - |
| Vertrieb & Marketing | - | - | |
| GAMIDA CELL LTD. | Corporate Officer/Principal | - | - |
Karriereverlauf von Stephen Joyce
Ehemalige bekannte Positionen von Stephen Joyce
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| Astellas Pharmaceuticals AG | Corporate Officer/Principal | 01.01.2018 | 01.11.2018 |
Astellas Pharma Europe Ltd.
 Astellas Pharma Europe Ltd. Pharmaceuticals: MajorHealth Technology Astellas Pharma Europe Ltd. engages in the development and sale of pharmaceutical products. The company is headquartered in Addlestone, the United Kingdom. | Corporate Officer/Principal | 01.04.2016 | 01.01.2018 |
Amryt Pharma Holdings Ltd.
 Amryt Pharma Holdings Ltd. Pharmaceuticals: MajorHealth Technology Amryt Pharma Holdings Ltd. is a pharmaceutical company, which engages in the development and delivery of treatments to help improve the lives of patients with rare and orphan diseases. Its products include Lomitapide and Metreleptin. The Lomitapide provides homozygous familial hypercholesterolemia (HoFH), and Metreleptin provides treatment for generalized lipodystrophy (GL) and partial lipodystrophy (PL). The company was founded on December 20, 2004 and is headquartered in London, the United Kingdom. | Public Communications Contact | - | - |
| Vertrieb & Marketing | - | - |
Ausbildung von Stephen Joyce
| Trinity College Dublin | Undergraduate Degree |
Statistik
International
| Vereinigtes Königreich | 4 |
| Irland | 2 |
| Schweiz | 2 |
Operativ
| Corporate Officer/Principal | 3 |
| Public Communications Contact | 2 |
| Sales & Marketing | 2 |
Sektoral
| Health Technology | 5 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| GAMIDA CELL LTD. | Health Technology |
| Private Unternehmen | 4 |
|---|---|
Amryt Pharma Holdings Ltd.
Amryt Pharma Holdings Ltd. Pharmaceuticals: MajorHealth Technology Amryt Pharma Holdings Ltd. is a pharmaceutical company, which engages in the development and delivery of treatments to help improve the lives of patients with rare and orphan diseases. Its products include Lomitapide and Metreleptin. The Lomitapide provides homozygous familial hypercholesterolemia (HoFH), and Metreleptin provides treatment for generalized lipodystrophy (GL) and partial lipodystrophy (PL). The company was founded on December 20, 2004 and is headquartered in London, the United Kingdom. | Health Technology |
Astellas Pharma Europe Ltd.
Astellas Pharma Europe Ltd. Pharmaceuticals: MajorHealth Technology Astellas Pharma Europe Ltd. engages in the development and sale of pharmaceutical products. The company is headquartered in Addlestone, the United Kingdom. | Health Technology |
| Astellas Pharmaceuticals AG | |
Amryt Pharma Plc
 Amryt Pharma Plc Pharmaceuticals: MajorHealth Technology Amryt Pharma Plc operates as a holding company with interests in the development and delivery of treatments to help improve the lives of patients with rare and orphan diseases. The company was founded on July 17, 2019 and is headquartered in Dublin, Ireland. | Health Technology |
- Börse
- Insiders
- Stephen Joyce
- Erfahrung
